Yuka Hirashita

5PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 29, 2026
Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma.

Shusaku Kurogi, Yoshiyuki Tsukamoto, Junpei Yamamura

|Aug 03, 2022
Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids.

Yoshiyuki Tsukamoto, Shusaku Kurogi, Tomotaka Shibata

|Apr 29, 2021
Early response in phosphorylation of ribosomal protein S6 is associated with sensitivity to trametinib in colorectal cancer cells.

Yuka Hirashita, Yoshiyuki Tsukamoto, Yoko Kudo

|Mar 08, 2021
α-Tocopherol suppresses hepatic steatosis by increasing CPT-1 expression in a mouse model of diet-induced nonalcoholic fatty liver disease.

Masanori Tokoro, Koro Gotoh, Yoko Kudo

|Mar 03, 2021
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.

Masaaki Kodama, Tadayoshi Okimoto, Kazuhiro Mizukami

Pageof 1

Frequent Collaborators

3 joint publications

Yoshiyuki Tsukamoto

1 joint publications

Masaaki Kodama

1 joint publications

Masanori Tokoro

1 joint publications

Koro Gotoh